Correlation Between Roivant Sciences and Madrigal Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Roivant Sciences and Madrigal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Roivant Sciences and Madrigal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Roivant Sciences and Madrigal Pharmaceuticals, you can compare the effects of market volatilities on Roivant Sciences and Madrigal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Roivant Sciences with a short position of Madrigal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Roivant Sciences and Madrigal Pharmaceuticals.
Diversification Opportunities for Roivant Sciences and Madrigal Pharmaceuticals
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Roivant and Madrigal is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Roivant Sciences and Madrigal Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Madrigal Pharmaceuticals and Roivant Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Roivant Sciences are associated (or correlated) with Madrigal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Madrigal Pharmaceuticals has no effect on the direction of Roivant Sciences i.e., Roivant Sciences and Madrigal Pharmaceuticals go up and down completely randomly.
Pair Corralation between Roivant Sciences and Madrigal Pharmaceuticals
Given the investment horizon of 90 days Roivant Sciences is expected to generate 0.81 times more return on investment than Madrigal Pharmaceuticals. However, Roivant Sciences is 1.23 times less risky than Madrigal Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Madrigal Pharmaceuticals is currently generating about 0.03 per unit of risk. If you would invest 942.00 in Roivant Sciences on August 31, 2024 and sell it today you would earn a total of 329.00 from holding Roivant Sciences or generate 34.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Roivant Sciences vs. Madrigal Pharmaceuticals
Performance |
| Timeline |
| Roivant Sciences |
| Madrigal Pharmaceuticals |
Roivant Sciences and Madrigal Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Roivant Sciences and Madrigal Pharmaceuticals
The main advantage of trading using opposite Roivant Sciences and Madrigal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Roivant Sciences position performs unexpectedly, Madrigal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Madrigal Pharmaceuticals will offset losses from the drop in Madrigal Pharmaceuticals' long position.| Roivant Sciences vs. Krystal Biotech | Roivant Sciences vs. Akero Therapeutics | Roivant Sciences vs. Apellis Pharmaceuticals | Roivant Sciences vs. Day One Biopharmaceuticals |
| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |